Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis.

Wang X, Gu H, Qin D, Yang L, Huang W, Essandoh K, Wang Y, Caldwell CC, Peng T, Zingarelli B, Fan GC. · 2015

Read Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis. by Wang X, Gu H, Qin D, Yang L, Huang W, Essandoh K, Wang Y, Caldwell CC, Peng T, Zingarelli B, Fan GC. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4562230.txt.

Introduction

Xiaohong Wang leads an eleven-author team tracing how stem cells protect the heart during sepsis, in Scientific Reports in 2015. Mesenchymal stem cells ease sepsis damage to the heart, but the messenger was unknown. A small RNA, miR-223, is packed richly in the exosomes these cells shed, making it a prime candidate.

Mice got sepsis through a standard gut puncture procedure. Normal stem cells protected the heart, cutting cell death and inflammation, and shed exosomes as they did. Stem cells lacking miR-223 gave no protection, and their exosomes actually worsened injury. Those faulty exosomes carried extra amounts of two proteins miR-223 normally suppresses, which then entered heart cells and stoked inflammation.

Catalog record

CREATORWang X, Gu H, Qin D, Yang L, Huang W, Essandoh K, Wang Y, Caldwell CC, Peng T, Zingarelli B, Fan GC.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE52 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4562230

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis By Xiaohong Wang, Haitao Gu, Dongze Qin, Liwang Yang, Wei Huang, Kobina Essandoh, Yigang Wang, Charles C. Caldwell, Tianqing Peng, Basilia Zingarelli, Guo-Chang Fan Published in: Scientific Reports DOI: 10.1038/srep13721 ABSTRACT Mesenchymal stem cells (MSCs) have been shown to elicit cardio-protective effects in sepsis. However, the underlying mechanism remains obscure. While recent studies have indicated that miR-223 is highly enriched in MSC-derived exosomes, whether exosomal miR-223 contributes to MSC-mediated cardio-protection in sepsis is unknown. In this study, loss-of-function approach was utilized, and sepsis was induced by cecal ligation and puncture (CLP). We observed that injection of miR-223-KO MSCs at 1 h post-CLP did not confer protection against CLP-triggered cardiac dysfunction, apoptosis and inflammatory response. However, WT-MSCs were able to provide protection which was associated with exosome release. Next, treatment of CLP mice with exosomes released from miR-223-KO MSCs significantly exaggerated sepsis-induced injury. Conversely, WT-MSC-derived-exosomes displayed protective effects. Mechanistically, we identified that miR-223-KO exosomes contained higher levels of Sema3A and Stat3, two known targets of miR-223 (5p & 3p), than WT-exosomes. Accordingly, these exosomal proteins were transferred to cardiomyocytes, leading to increased inflammation and cell death. By contrast, WT-exosomes encased higher levels of miR-223, which could be delivered to cardiomyocytes, resulting in down-regulation of Sema3A and Stat3. These data for the first time indicate that exosomal miR-223 plays an essential role for MSC-induced cardio-protection in sepsis. Sepsis is a systemic inflammation response to a local severe infection that can lead to multiple organ failure and ultimately, death1. Cardiac injury and dysfunction, commonly observed in septic patients, contribute substantially to the cardiovascular collapse, resulting in poor perfusion of blood into multiple tissues2. Therefore, strategies aimed to protect depressed hearts during sepsis would provide beneficial effects on mortality in this complex disease. Over the past years, mesenchymal stem cells (MSCs) originating from either bone marrow or adipose tissue have been consistently shown effective at reducing mortality and improving myocardial function in endotoxin-treated animals and preclinical models of polymicrobial sepsis induced by cecal ligation and puncture (CLP)34567. The beneficial role of MSCs in these studies was believed to be primarily attributed to the interaction of MSCs with host macrophages in circulation and tissues, resulting in a reduced secretion of pro-inflammatory cytokines (i.e., TNF-α, IL-1β, and IL-6) from macrophages34567. However, it remains unclear how MSCs interact with macrophages and other types of cells during sepsis. As a matter of fact, it has been documented that MSCs, when infused systemically in septic animal models, home mainly to the lung and the liver in a short time (5-10min after injection)3589. Especially, these MSCs are not able to be detected in cardiac tissue5. Hence, MSC-induced cardiac benefits during sepsis may not be related to their local actions but their systemic effects. Nonetheless, the mechanisms underlying MSC-mediated cardio-protection in sepsis are still obscure. Recently, exosomes have been widely reported to mediate local and systemic cell-to-cell communication10111213. They are nanometer-sized membrane vesicles (30–100 nm) released from numerous cell types upon fusion of multivesicular bodies (late endosomes) with the cell membrane. Numerous studies have demonstrated that exosomes can transfer a specific set of functional RNAs (miRNAs and mRNAs) and proteins into recipient cells through direct fusion of exosomes with the cell membrane or through active uptake, mediated by endocytosis10111213. Of interest, several recent studies have implicated exosomes as key effectors of MSC paracrine function and shown that exosomes released from MSCs were able to improve recovery in animal models of kidney failure, liver fibrosis, myocardial ischemia/reperfusion injury, hypoxia-induced pulmonary hypertension, and cerebral ischemia1415161718. However, whether exosomes also contribute to MSC-induced cardio-protection against septic shock remains to be clarified. Currently, it is well recognized that the functional significance of exosomes is dependent on the exosomal contents (miRNAs, mRNAs and proteins)11. In particular, miRNAs have been implicated as important exosomal components and largely decide the effects of exosomes on recipient cells11. For example, miR-146a is highly enriched in exosomes released from cardiosphere-derived cells and confers protection against myocardial infarction, whereas their capacity to protect stressed hearts is diminished by knockdown of exosomal miR-146a19. MiR-223 is the most highly expressed miRNA in both human peripheral blood mononuclear cells (PBMCs) and animal bone marrow-derived mesenchymal stem cells (MSCs)2021. Significantly, miR-223 is highly encased in exosomes released from PBMCs and MSCs2021. Numerous studies have indicated that miR-223 can negatively regulate the expression of many inflammatory genes (i.e., IL-6 and NLRP3)21. Importantly, our prior work also showed that loss of miR-223 aggravated myocardial depression and mortality in polymicrobial sepsis through up-regulation of Sema3A and Stat3, two known inflammation-related genes22. Therefore, we speculated that miR-223 may be critical for MSC-elicited action in sepsis. To this end, miR-223-KO MSCs were employed in septic mice induced by cecal ligation and puncture (CLP), and wild-type (WT) MSCs were used as controls. We further determined the effects of exosomes released from miR-223-KO MSCs on sepsis-induced inflammatory response, cardiac dysfunction and mortality. Finally, the possible underlying mechanisms were identified in this work. We believe that our study may provide a novel basis to the development of cell-free therapeutic approach for the treatment of sepsis. RESULTS Administration of miR-223-KO MSCs does not improve animal survival and cardiac function in CLP-induced sepsis model To address whether miR-223 contributes to MSC-induced protection in sepsis, we harvested MSCs from bone marrow of female miR-223 KO (miR-223−/−) mice. MSCs derived from female wild-type (WT) bone marrow were used as controls. MiR-223-KO MSCs were phenotypically similar to WTs, and expressed mesenchymal markers (i.e. CD29 and Sca-1), but not hematopoietic markers (i.e. CD34) (Fig. 1A–H). We also validated that the expression of both strands (miR-223-5p and miR-223-3p) was deficient in MSCs collected from miR-223-KO mice (Fig. 1I). To understand the functional significance of miR-223 in MSC-mediated protection against sepsis injury, miR-223-KO MSCs and controls were administered intravenously to male WT mice at 1 h post-CLP surgery. We observed that survival rate was significantly improved in CLP-mice treated with WT-MSCs, as evidenced by 58% of the mice (n = 12) survived until the end of day 3, when only 20% of PBS-treated mice survived (n = 10) (Fig. 1J). These results are consistent with previous reports3. However, CLP-mice treated with miR-223-null MSCs (n = 14) did not exhibit an improved survival, compared to PBS-treated controls (Fig. 1J). This suggests that miR-223 may be essential for MSC-elicited beneficial effects on survival during polymicrobial sepsis. We next determined whether miR-223 affects MSC-induced cardio-protection in sepsis. Cardiac function was measured by echocardiography in CLP mice treated with miR-223-KO MSCs or controls. We observed that hearts of CLP-mice treated with WT-MSCs had improved values of left ventricular ejection fraction (EF %) and fractional shortening (FS %), compared with the vehicle PBS group at 12 h post-CLP (Fig. 1K–M, p < 0.05). By contrast, no difference in either EF% or FS% was identified between the miR-223-KO MSC- and the vehicle-treated groups (Fig. 1K–M). Numerous studies have indicated that sepsis-induced myocardial dysfunction may be directly ascribed to cardiomyocyte damage232425. As a matter of fact, few apoptotic cadiomyocytes were detected by TUNEL staining in sham-operated mice (Fig. 1N,O). However, extensive apoptotic nuclei (∼8/1000 nuclei) were observed in the myocardium of vehicle-treated mice at 12 h post-CLP surgery

Read the complete text